
|Articles|August 4, 2019
Avedro, Inc., company update: Epi-on crosslinking (CXL) and PiXL technology
Author(s)Julianne Mobilian
ICYMI: Here's what's in the 2019 pipeline
Advertisement
Rajesh Rajpal, MD, Chief Medical Officer of Avedro, Inc., provides a company update on Epi-on crosslinking (CXL) and PiXL technology during the 2019 ASCRS conference in San Diego.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
Long-lived Greenland sharks may point to new approaches for retinal disease
4
Orbital and retinal microvascular changes in thyroid eye disease
5












































